3‐Hydroxyacyl‐CoA dehydrogenase and short chain 3‐hydroxyacyl‐CoA dehydrogenase in human health and disease

3‐Hydroxyacyl‐CoA dehydrogenase (HAD) functions in mitochondrial fatty acid β‐oxidation by catalyzing the oxidation of straight chain 3‐hydroxyacyl‐CoAs. HAD has a preference for medium chain substrates, whereas short chain 3‐hydroxyacyl‐CoA dehydrogenase (SCHAD) acts on a wide spectrum of substrates, including steroids, cholic acids, and fatty acids, with a preference for short chain methyl‐branched acyl‐CoAs. Therefore, HAD should not be referred to as SCHAD. SCHAD is not a member of the HAD family, but instead, belongs to the short chain dehydrogenase/reductase superfamily. Previously reported cases of SCHAD deficiency are due to an inherited HAD deficiency. SCHAD, also known as 17β‐hydroxysteroid dehydrogenase type 10, is important in brain development and aging. Abnormal levels of SCHAD in certain brain regions may contribute to the pathogenesis of some neural disorders. The human SCHAD gene and its protein product, SCHAD, are potential targets for intervention in conditions, such as Alzheimer's disease, Parkinson's disease, and an X‐linked mental retardation, that may arise from the impaired degradation of branched chain fatty acid and isoleucine.

[1]  Y. Shi,et al.  Cloning of an L-3-hydroxyacyl-CoA dehydrogenase that interacts with the GLUT4 C-terminus. , 1999, Archives of biochemistry and biophysics.

[2]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Yang,et al.  Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease. , 2001, Advances in experimental medicine and biology.

[4]  R. Wanders,et al.  Report 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency Is Caused by Mutations in the HADH 2 Gene , 2003 .

[5]  B. Middleton,et al.  The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria. , 1982, Biochimica et biophysica acta.

[6]  T. Hashimoto,et al.  Purification and properties of mitochondrial and peroxisomal 3-hydroxyacyl-CoA dehydrogenase from rat liver. , 1980, Archives of biochemistry and biophysics.

[7]  Song-Yu Yang,et al.  The large subunit of the pig heart mitochondrial membrane-bound beta-oxidation complex is a long-chain enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. , 1994, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[8]  Song-Yu Yang,et al.  A Human Brain l-3-Hydroxyacyl-coenzyme A Dehydrogenase Is Identical to an Amyloid β-Peptide-binding Protein Involved in Alzheimer’s Disease* , 1998, The Journal of Biological Chemistry.

[9]  Song-Yu Yang,et al.  Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors , 2005, Molecular and Cellular Endocrinology.

[10]  T. Hashimoto,et al.  Molecular cloning of the cDNAs for the subunits of rat mitochondrial fatty acid beta-oxidation multienzyme complex. Structural and functional relationships to other mitochondrial and peroxisomal beta-oxidation enzymes. , 1993, The Journal of biological chemistry.

[11]  B. Persson,et al.  Short-chain dehydrogenases/reductases. , 1995, Advances in experimental medicine and biology.

[12]  P. Rinaldo.  Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. , 1999, Digestive diseases and sciences.

[13]  R. Wanders,et al.  Fatal Hepatic Short-Chain L-3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency: Clinical, Biochemical, and Pathological Studies on Three Subjects with This Recently Identified Disorder of Mitochondrial β-Oxidation , 1999, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[14]  Song-Yu Yang,et al.  Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. , 2005, Trends in endocrinology and metabolism: TEM.

[15]  T. Hashimoto,et al.  A new inhibitor of mitochondrial fatty acid oxidation. , 1996, Journal of biochemistry.

[16]  W. D. de Jong,et al.  Lambda-crystallin, a major rabbit lens protein, is related to hydroxyacyl-coenzyme A dehydrogenases. , 1988, The Journal of biological chemistry.

[17]  L. Banaszak,et al.  Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism. , 1999, Biochemistry.

[18]  M. Bennett,et al.  Mitochondrial Short-Chain L-3-Hydroxyacl-Coenzyme A Dehydrogenase Deficiency: A New Defect of Fatty Acid Oxidation , 1996, Pediatric Research.

[19]  L. Tjernberg,et al.  Binding of amyloid β‐peptide to mitochondrial hydroxyacyl‐CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease , 1999 .

[20]  H. Schulz,et al.  Mitochondrial β-Oxidation of 2-Methyl Fatty Acids in Rat Liver , 1995 .

[21]  T Hashimoto,et al.  Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. , 1992, The Journal of biological chemistry.

[22]  Song-Yu Yang,et al.  Characterization and localization of human type10 17β-hydroxysteroid dehydrogenase , 2001 .

[23]  N. Xuong,et al.  Structure of L-3-hydroxyacyl-coenzyme A dehydrogenase: preliminary chain tracing at 2.8-A resolution. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Vila,et al.  MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease , 2004, Journal of bioenergetics and biomembranes.

[25]  H. Schulz,et al.  Short-chain 3-hydroxy-2-methylacyl-CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism. , 1995, Archives of biochemistry and biophysics.

[26]  Ronald J A Wanders,et al.  Clinical variability in 3‐hydroxy‐2‐methylbutyryl‐coa dehydrogenase deficiency , 2002, Annals of neurology.

[27]  J. Vockley,et al.  Defects of mitochondrial β-oxidation: a growing group of disorders , 2002, Neuromuscular Disorders.

[28]  R. Bradshaw,et al.  L-3-hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. II. Subunit structure. , 1973, The Journal of biological chemistry.

[29]  R. Wanders,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man , 2002, Journal of Inherited Metabolic Disease.

[30]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[31]  H. Sprecher,et al.  Purification and characterization of the trifunctional beta-oxidation complex from pig heart mitochondria. , 1993, Archives of biochemistry and biophysics.

[32]  S. Dimauro,et al.  Short‐chain L‐3‐hydroxyacyl‐CoA dehydrogenase deficiency in muscle: A new cause for recurrent myoglobinuria and encephalopathy , 1991, Annals of neurology.

[33]  L. Banaszak,et al.  Sequestration of the active site by interdomain shifting. Crystallographic and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase. , 2000, The Journal of biological chemistry.

[34]  Steven G. Clarke,et al.  Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* , 1999, The Journal of Biological Chemistry.

[35]  R. Wanders,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. , 2003, American journal of human genetics.

[36]  R. Bradshaw,et al.  L-3-hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. EC 1.1.1.35 L-3-hydroxyacyl-CoA: NAD oxidoreductase. , 1975, Methods in enzymology.

[37]  M. Vila,et al.  L‐3‐hydroxyacyl‐CoA dehydrogenase II protects in a model of Parkinson's disease , 2004, Annals of neurology.

[38]  M. Israel,et al.  Molecular cloning and primary structure of human glial fibrillary acidic protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Hashimoto Takashi,et al.  Occurrence of two 3-Hydroxyacyl-CoA dehydrogenases in rat liver , 1979 .

[40]  R. Bradshaw,et al.  L-3-hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. I. Purification and properties. , 1973, The Journal of biological chemistry.

[41]  F. Blecha,et al.  Identity of heart and liver L-3-hydroxyacyl coenzyme A dehydrogenase. , 1999, Biochimica et biophysica acta.

[42]  Song-Yu Yang,et al.  Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase. , 2000, The Biochemical journal.

[43]  S. Yang,et al.  Histidine-450 is the catalytic residue of L-3-hydroxyacyl coenzyme A dehydrogenase associated with the large alpha-subunit of the multienzyme complex of fatty acid oxidation from Escherichia coli. , 1996, Biochemistry.

[44]  D. van der A,et al.  Structural organization of the human short-chain L-3-hydroxyacyl-CoA dehydrogenase gene , 1998, Mammalian Genome.

[45]  R. Wanders,et al.  Progressive Infantile Neurodegeneration Caused by 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency: A Novel Inborn Error of Branched-Chain Fatty Acid and Isoleucine Metabolism , 2000, Pediatric Research.

[46]  Song-Yu Yang,et al.  Molecular Mechanisms of Fatty Acid β-Oxidation Enzyme Catalysis , 2002 .

[47]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[48]  M. Pourfarzam,et al.  Defects of β-oxidation including carnitine deficiency , 2002 .

[49]  L. Banaszak,et al.  Glutamate 170 of Human l-3-Hydroxyacyl-CoA Dehydrogenase Is Required for Proper Orientation of the Catalytic Histidine and Structural Integrity of the Enzyme* , 2001, The Journal of Biological Chemistry.

[50]  H. Schulz,et al.  Kinetics of coupled enzyme reactions. , 1987, Biochemistry.

[51]  J. Thyberg,et al.  Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. , 2003, The Biochemical journal.

[52]  D. Olde Weghuis,et al.  Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. , 1996, Biochemical and biophysical research communications.

[53]  P. Clayton,et al.  Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. , 2001, The Journal of clinical investigation.

[54]  R. Bradshaw,et al.  [16]l-3-hydroxyacyl coenzyme A dehydrogenase from pig heart muscle , 1975 .

[55]  Song-Yu Yang,et al.  Assay of L-3-hydroxyacyl-coenzyme A dehydrogenase with substrates of different chain lengths. , 1989, Analytical biochemistry.

[56]  T. Hashimoto,et al.  Occurrence of two 3-hydroxyacyl-CoA dehydrogenases in rat liver. , 1979, Biochimica et biophysica acta.

[57]  Dörte Stephan,et al.  3-Hydroxyacyl-CoA Dehydrogenase , 2020, Definitions.

[58]  H. Kindl,et al.  Domains of the tetrafunctional protein acting in glyoxysomal fatty acid beta-oxidation. Demonstration of epimerase and isomerase activities on a peptide lacking hydratase activity. , 1994, The Journal of biological chemistry.

[59]  P. Rejto,et al.  Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. , 2004, Journal of molecular biology.

[60]  O. R-CH2-CH2-CH,et al.  FATTY acid oxidation. , 1946, Nutrition reviews.

[61]  S. Yang,et al.  Molecular cloning, expression in Escherichia coli, and characterization of a novel L-3-hydroxyacyl coenzyme A dehydrogenase from pig liver. , 1998, Biochimica et biophysica acta.

[62]  M. Elzinga,et al.  Nucleotide sequence of the promoter and fadB gene of the fadBA operon and primary structure of the multifunctional fatty acid oxidation protein from Escherichia coli. , 1991, Biochemistry.

[63]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[64]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[65]  Short-chain dehydrogenases/reductases (SDR). , 1995 .

[66]  M Krook,et al.  Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.

[67]  Song-Yu Yang,et al.  Function of human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism. , 2000, Biochimica et biophysica acta.

[68]  J. Wegiel,et al.  Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase , 2005, Brain Research.

[69]  Piero Rinaldo,et al.  Fatty acid oxidation disorders. , 2002, Annual review of physiology.

[70]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[71]  Song-Yu Yang,et al.  Multiple functions of type 10 17β-hydroxysteroid dehydrogenase , 2005, Trends in Endocrinology & Metabolism.

[72]  K. Carpenter,et al.  Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. , 1992, Biochemical and biophysical research communications.

[73]  J. Vockley,et al.  Short-chain hydroxyacyl-coenzyme A dehydrogenase deficiency presenting as unexpected infant death: A family study. , 2000, The Journal of pediatrics.

[74]  H. Kagamiyama,et al.  Molecular cloning and nucleotide sequence of the cDNA for rat peroxisomal enoyl-CoA: hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. , 1985, The Journal of biological chemistry.

[75]  Dennis Dickson,et al.  Deposition of Alzheimer’s vascular amyloid-β is associated with decreased expression of brain l-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB) , 2001, Brain Research.

[76]  R. Bradshaw,et al.  Amino acid sequence of L‐3‐hydroxyacyl CoA dehydrogenase from pig heart muscle , 1980, FEBS letters.

[77]  Song-Yu Yang,et al.  Human Brain Short Chain l-3-Hydroxyacyl Coenzyme A Dehydrogenase Is a Single-domain Multifunctional Enzyme , 1999, The Journal of Biological Chemistry.

[78]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology , 1987 .

[79]  T. Hashimoto,et al.  Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver. , 1996, Journal of biochemistry.

[80]  Xi Chen,et al.  An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease , 1997, Nature.